Biogen's Alzheimer's Drug To Enter New Trial Stage Next Year
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn something new every day.
Biogen's Alzheimer's drug Aduhelm was approved for sale by the FDA in June. But whether or not it actually works is another question entirely.
Thanks to a new accelerated trial timeline announced by the company on Thursday, the answer to that all-important question will come sooner than expected.
Source Fool.com
